Published in J Neurochem on February 01, 1994
Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Exp Neurol (2008) 1.06
Selective vulnerability of late-generated dopaminergic neurons of the substantia nigra in weaver mutant mice. Proc Natl Acad Sci U S A (1995) 0.85
Atrophy and loss of dopaminergic mesencephalic neurons in heterozygous weaver mice. Exp Brain Res (1997) 0.77
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A (1998) 6.13
Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet (1997) 4.11
Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science (1991) 4.09
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (1999) 2.43
Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron (1998) 2.40
Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology (1990) 2.36
Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A (1997) 1.89
Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol (1973) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol (1998) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J (1991) 1.74
Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci U S A (1999) 1.73
Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol (1983) 1.72
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell (1994) 1.69
Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci U S A (1993) 1.68
Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat Genet (1992) 1.66
Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol (1999) 1.49
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol (1998) 1.48
Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet (1992) 1.41
Ganciclovir-induced psychosis. N Engl J Med (1996) 1.39
Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol (1999) 1.38
A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem (2000) 1.34
Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33
Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A (2000) 1.31
Study on the propagation of Herpes simplex virus (type 2) into the brain after intraocular injection. Brain Res (1974) 1.31
Whole-exome sequencing and imaging genetics identify functional variants for rate of change in hippocampal volume in mild cognitive impairment. Mol Psychiatry (2013) 1.30
On the association between microtubules and mitochondria within axons. Brain Res (1971) 1.18
Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp Brain Res (1995) 1.18
Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol (2001) 1.18
Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol (2001) 1.14
Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg (1993) 1.13
Neuropsychological function in nondemented carriers of presenilin-1 mutations. Neurology (2005) 1.13
Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol (1999) 1.12
Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology (2007) 1.11
Neurofibrillary tangles in Niemann-Pick disease type C. Acta Neuropathol (1995) 1.11
Positron emission tomography with 18fluorine-labelled deoxyglucose: utility in localized and advanced prostate cancer. BJU Int (1999) 1.10
Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology (1996) 1.10
Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci U S A (1992) 1.09
Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy. J Neuropathol Exp Neurol (2000) 1.08
Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol (2001) 1.07
Dopamine deficiency in the weaver mutant mouse. J Neurosci (1982) 1.07
Tolerance to opioid narcotics, II. Cellular tolerance to levorphanol in mouse brain. Proc Natl Acad Sci U S A (1970) 1.07
Proteinase-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred). J Neuropathol Exp Neurol (1996) 1.04
Isolation of ( 3 H) acetylcholine pools by subcellular fractionation of cerebral cortex slices incubated with ( 3 H) choline. J Neurochem (1971) 1.03
Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol (2000) 1.03
Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease. Life Sci (1980) 1.00
[Contribution of time of flight and point spread function modeling to the performance characteristics of the PET/CT Biograph mCT scanner]. Rev Esp Med Nucl Imagen Mol (2012) 1.00
The distribution of inhaled mercury(Hg203) vapors in the brain of rats and mice. J Neuropathol Exp Neurol (1969) 0.99
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process. Ann N Y Acad Sci (2000) 0.99
A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease. Arch Neurol (2001) 0.99
Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17. Am J Hum Genet (1997) 0.99
Early-onset Alzheimer disease caused by a new mutation (V717L) in the amyloid precursor protein gene. Arch Neurol (2000) 0.98
Quantitative volumetric analysis of gliomas with sequential MRI and ¹¹C-methionine PET assessment: patterns of integration in therapy planning. Eur J Nucl Med Mol Imaging (2012) 0.98
Subacute sclerosing panencephalitis manifesting as viral retinitis: clinical and histopathologic findings. Am J Ophthalmol (1997) 0.97
Gerstmann-Sträussler-Scheinker disease. I. Extending the clinical spectrum. Neurology (1989) 0.97
A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Brain Res (1993) 0.97
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol (1995) 0.97
Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology (1999) 0.96
Alzheimer patients and Down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits. Neurosci Lett (1990) 0.96
Neuropathology of Gerstmann-Sträussler-Scheinker disease. Microsc Res Tech (2000) 0.95
Beta PP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol (1993) 0.95
Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures? J Cardiothorac Vasc Anesth (1999) 0.95
Cerebellar plaques in familial Alzheimer's disease (Gerstmann-Sträussler-Scheinker variant?). Acta Neuropathol (1985) 0.95
Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis. J Rheumatol (1980) 0.94
The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1991) 0.94
A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. Am J Pathol (1999) 0.94
Phenotypic variability in three families with valosin-containing protein mutation. Eur J Neurol (2012) 0.94
An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Am J Pathol (1998) 0.93
Neurofibrillary tangles of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease share antigenic determinants with those of Alzheimer disease. Brain Res (1990) 0.93
Barbiturates: their in vivo effects and potential biochemical mechanisms. Prog Neurobiol (1982) 0.92
Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis (2001) 0.91
Alzheimer patients: preamyloid deposits are more widely distributed than senile plaques throughout the central nervous system. Neurosci Lett (1989) 0.91
High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2000) 0.91
The weaver mutation changes the ion selectivity of the affected inwardly rectifying potassium channel GIRK2. FEBS Lett (1996) 0.91
Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease. Neurology (2002) 0.91
Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease. Neuropathol Appl Neurobiol (2006) 0.90
A novel leukoencephalopathy associated with tau deposits primarily in white matter glia. Acta Neuropathol (2003) 0.90
Induction of neurofibrillary degeneration following treatment with maytansine in vivo. Brain Res (1979) 0.90
Influence of combined zero-balanced and modified ultrafiltration on the systemic inflammatory response during coronary artery bypass grafting. J Cardiothorac Vasc Anesth (1999) 0.89
Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice. Exp Brain Res (1988) 0.89
A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy. Acta Neuropathol (1999) 0.89
Reduction of blood utilization during myocardial revascularization. J Thorac Cardiovasc Surg (1989) 0.88
[Experiences with Swan-Ganz-catheter placement in the external jugular vein]. Anaesthesist (1985) 0.88
Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm (Vienna) (2007) 0.88
Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. Acta Neuropathol (2000) 0.88
Synthesis of radioactive acetylcholine from ( 3 H)choline and its release from cerebral cortex slices in vitro. J Neurochem (1971) 0.87
Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology (2002) 0.87
PrP27-30 is a normal soluble prion protein fragment released by human platelets. Biochem Biophys Res Commun (1996) 0.87
Biochemical characterization of a neuroserpin variant associated with hereditary dementia. Am J Pathol (2001) 0.87
Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology (1995) 0.86
High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. J Cardiothorac Vasc Anesth (1992) 0.86
Effect of aging on neurotransmitter receptor binding in rat and human brain. Life Sci (1979) 0.86
Progressive supranuclear palsy with hypertrophy of the olives. An immunocytochemical study of the cytoskeleton of argyrophilic neurons. Acta Neuropathol (1988) 0.86